%0 Journal Article
%T Beneficial Effects of Adalimumab Counteracted in Patient with Common Variable Immunodeficiency Disorder (CVID) Receiving IVIG: Case Report
%A Trisha Sharma
%A null
%J Journal of Allergy and Clinical Immunology
%D 2017
%R 10.1016/j.jaci.2016.12.025
%X Adalimumab is a monoclonal antibody (mAb) against TNF alpha used to treat rheumatoid
arthritis (RA). Despite prevalence of autoimmune disease in CVID, there are no published
cases of negative interactions between IVIG and adalimumab.
%U https://www.jacionline.org/article/S0091-6749(16)31543-3/abstract